中国生物制药(01177.HK) 公布截至去年12月底止全年业绩，营业额288.66亿元人民币(下同)，按年升10.2%。纯利35亿元，按年升50.1%；每股盈利19.13分。派末期息4港仙，上年同期派3港仙。连同已派发中期股息3港仙，全年合共派发股息7港仙。非《香港财务报告准则》计，经调整纯利按年升33.5%至约34.6亿元。每股经调整盈利18.9分。期内，毛利率按年升0.5个百分点至81.5%...
Source Link中国生物制药(01177.HK) 公布截至去年12月底止全年业绩，营业额288.66亿元人民币(下同)，按年升10.2%。纯利35亿元，按年升50.1%；每股盈利19.13分。派末期息4港仙，上年同期派3港仙。连同已派发中期股息3港仙，全年合共派发股息7港仙。非《香港财务报告准则》计，经调整纯利按年升33.5%至约34.6亿元。每股经调整盈利18.9分。期内，毛利率按年升0.5个百分点至81.5%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.